Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
This study has been terminated.
( Lack of drug supply for doxercalciferol for this study )
Study NCT00582582   Information provided by University of Wisconsin, Madison

First Received on December 19, 2007.   Last Updated on April 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Docetaxel plus doxercalciferol
Docetaxel plus placebo
Additional drug interventions recognized in this trial
1 alpha-hydroxyergocalciferol
Dihydroxycholecalciferols
Docetaxel
Ergocalciferols
Hydroxycholecalciferols
More general drug interventions related to this trial
Antineoplastic Agents
Bone Density Conservation Agents
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vitamins
Sponsors listed in this trial
University of Wisconsin, Madison
Sanofi
Genzyme


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services